Global Equine Rhinopneumonitis Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 97

Published Date: 10 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

Equine Rhinopneumonitis Vaccine can prevent Equine Rhinopneumonitis，viruses that are prevalent in horses and can cause outbreaks of respiratory disease.

According to our (Global Info Research) latest study, the global Equine Rhinopneumonitis Vaccine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Equine Rhinopneumonitis Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Equine Rhinopneumonitis Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Equine Rhinopneumonitis Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Equine Rhinopneumonitis Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Equine Rhinopneumonitis Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Equine Rhinopneumonitis Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Equine Rhinopneumonitis Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Zoetis, Nisseiken Co., Ltd., Boehringer Ingelheim, Santa Cruz Animal Health and Merck. etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Equine Rhinopneumonitis Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Live
    Inactivated

Market segment by Application
    Veterinary Pharmacy
    Online Sale
    Others

Major players covered
    Zoetis
    Nisseiken Co., Ltd.
    Boehringer Ingelheim
    Santa Cruz Animal Health
    Merck

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Equine Rhinopneumonitis Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Equine Rhinopneumonitis Vaccine, with price, sales, revenue and global market share of Equine Rhinopneumonitis Vaccine from 2018 to 2023.
Chapter 3, the Equine Rhinopneumonitis Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Equine Rhinopneumonitis Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Equine Rhinopneumonitis Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Equine Rhinopneumonitis Vaccine.
Chapter 14 and 15, to describe Equine Rhinopneumonitis Vaccine sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Equine Rhinopneumonitis Vaccine
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Equine Rhinopneumonitis Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Live
        1.3.3 Inactivated
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Equine Rhinopneumonitis Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Veterinary Pharmacy
        1.4.3 Online Sale
        1.4.4 Others
    1.5 Global Equine Rhinopneumonitis Vaccine Market Size & Forecast
        1.5.1 Global Equine Rhinopneumonitis Vaccine Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Equine Rhinopneumonitis Vaccine Sales Quantity (2018-2029)
        1.5.3 Global Equine Rhinopneumonitis Vaccine Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 Zoetis
        2.1.1 Zoetis Details
        2.1.2 Zoetis Major Business
        2.1.3 Zoetis Equine Rhinopneumonitis Vaccine Product and Services
        2.1.4 Zoetis Equine Rhinopneumonitis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Zoetis Recent Developments/Updates
    2.2 Nisseiken Co., Ltd.
        2.2.1 Nisseiken Co., Ltd. Details
        2.2.2 Nisseiken Co., Ltd. Major Business
        2.2.3 Nisseiken Co., Ltd. Equine Rhinopneumonitis Vaccine Product and Services
        2.2.4 Nisseiken Co., Ltd. Equine Rhinopneumonitis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Nisseiken Co., Ltd. Recent Developments/Updates
    2.3 Boehringer Ingelheim
        2.3.1 Boehringer Ingelheim Details
        2.3.2 Boehringer Ingelheim Major Business
        2.3.3 Boehringer Ingelheim Equine Rhinopneumonitis Vaccine Product and Services
        2.3.4 Boehringer Ingelheim Equine Rhinopneumonitis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Boehringer Ingelheim Recent Developments/Updates
    2.4 Santa Cruz Animal Health
        2.4.1 Santa Cruz Animal Health Details
        2.4.2 Santa Cruz Animal Health Major Business
        2.4.3 Santa Cruz Animal Health Equine Rhinopneumonitis Vaccine Product and Services
        2.4.4 Santa Cruz Animal Health Equine Rhinopneumonitis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Santa Cruz Animal Health Recent Developments/Updates
    2.5 Merck
        2.5.1 Merck Details
        2.5.2 Merck Major Business
        2.5.3 Merck Equine Rhinopneumonitis Vaccine Product and Services
        2.5.4 Merck Equine Rhinopneumonitis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Merck Recent Developments/Updates

3 Competitive Environment: Equine Rhinopneumonitis Vaccine by Manufacturer
    3.1 Global Equine Rhinopneumonitis Vaccine Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Equine Rhinopneumonitis Vaccine Revenue by Manufacturer (2018-2023)
    3.3 Global Equine Rhinopneumonitis Vaccine Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Equine Rhinopneumonitis Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Equine Rhinopneumonitis Vaccine Manufacturer Market Share in 2022
        3.4.2 Top 6 Equine Rhinopneumonitis Vaccine Manufacturer Market Share in 2022
    3.5 Equine Rhinopneumonitis Vaccine Market: Overall Company Footprint Analysis
        3.5.1 Equine Rhinopneumonitis Vaccine Market: Region Footprint
        3.5.2 Equine Rhinopneumonitis Vaccine Market: Company Product Type Footprint
        3.5.3 Equine Rhinopneumonitis Vaccine Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Equine Rhinopneumonitis Vaccine Market Size by Region
        4.1.1 Global Equine Rhinopneumonitis Vaccine Sales Quantity by Region (2018-2029)
        4.1.2 Global Equine Rhinopneumonitis Vaccine Consumption Value by Region (2018-2029)
        4.1.3 Global Equine Rhinopneumonitis Vaccine Average Price by Region (2018-2029)
    4.2 North America Equine Rhinopneumonitis Vaccine Consumption Value (2018-2029)
    4.3 Europe Equine Rhinopneumonitis Vaccine Consumption Value (2018-2029)
    4.4 Asia-Pacific Equine Rhinopneumonitis Vaccine Consumption Value (2018-2029)
    4.5 South America Equine Rhinopneumonitis Vaccine Consumption Value (2018-2029)
    4.6 Middle East and Africa Equine Rhinopneumonitis Vaccine Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global Equine Rhinopneumonitis Vaccine Sales Quantity by Type (2018-2029)
    5.2 Global Equine Rhinopneumonitis Vaccine Consumption Value by Type (2018-2029)
    5.3 Global Equine Rhinopneumonitis Vaccine Average Price by Type (2018-2029)

6 Market Segment by Application
    6.1 Global Equine Rhinopneumonitis Vaccine Sales Quantity by Application (2018-2029)
    6.2 Global Equine Rhinopneumonitis Vaccine Consumption Value by Application (2018-2029)
    6.3 Global Equine Rhinopneumonitis Vaccine Average Price by Application (2018-2029)

7 North America
    7.1 North America Equine Rhinopneumonitis Vaccine Sales Quantity by Type (2018-2029)
    7.2 North America Equine Rhinopneumonitis Vaccine Sales Quantity by Application (2018-2029)
    7.3 North America Equine Rhinopneumonitis Vaccine Market Size by Country
        7.3.1 North America Equine Rhinopneumonitis Vaccine Sales Quantity by Country (2018-2029)
        7.3.2 North America Equine Rhinopneumonitis Vaccine Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe Equine Rhinopneumonitis Vaccine Sales Quantity by Type (2018-2029)
    8.2 Europe Equine Rhinopneumonitis Vaccine Sales Quantity by Application (2018-2029)
    8.3 Europe Equine Rhinopneumonitis Vaccine Market Size by Country
        8.3.1 Europe Equine Rhinopneumonitis Vaccine Sales Quantity by Country (2018-2029)
        8.3.2 Europe Equine Rhinopneumonitis Vaccine Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific Equine Rhinopneumonitis Vaccine Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Equine Rhinopneumonitis Vaccine Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Equine Rhinopneumonitis Vaccine Market Size by Region
        9.3.1 Asia-Pacific Equine Rhinopneumonitis Vaccine Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Equine Rhinopneumonitis Vaccine Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America Equine Rhinopneumonitis Vaccine Sales Quantity by Type (2018-2029)
    10.2 South America Equine Rhinopneumonitis Vaccine Sales Quantity by Application (2018-2029)
    10.3 South America Equine Rhinopneumonitis Vaccine Market Size by Country
        10.3.1 South America Equine Rhinopneumonitis Vaccine Sales Quantity by Country (2018-2029)
        10.3.2 South America Equine Rhinopneumonitis Vaccine Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa Equine Rhinopneumonitis Vaccine Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Equine Rhinopneumonitis Vaccine Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Equine Rhinopneumonitis Vaccine Market Size by Country
        11.3.1 Middle East & Africa Equine Rhinopneumonitis Vaccine Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Equine Rhinopneumonitis Vaccine Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 Equine Rhinopneumonitis Vaccine Market Drivers
    12.2 Equine Rhinopneumonitis Vaccine Market Restraints
    12.3 Equine Rhinopneumonitis Vaccine Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
    13.1 Raw Material of Equine Rhinopneumonitis Vaccine and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Equine Rhinopneumonitis Vaccine
    13.3 Equine Rhinopneumonitis Vaccine Production Process
    13.4 Equine Rhinopneumonitis Vaccine Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Equine Rhinopneumonitis Vaccine Typical Distributors
    14.3 Equine Rhinopneumonitis Vaccine Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Equine Rhinopneumonitis Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Equine Rhinopneumonitis Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Zoetis Basic Information, Manufacturing Base and Competitors
    Table 4. Zoetis Major Business
    Table 5. Zoetis Equine Rhinopneumonitis Vaccine Product and Services
    Table 6. Zoetis Equine Rhinopneumonitis Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. Zoetis Recent Developments/Updates
    Table 8. Nisseiken Co., Ltd. Basic Information, Manufacturing Base and Competitors
    Table 9. Nisseiken Co., Ltd. Major Business
    Table 10. Nisseiken Co., Ltd. Equine Rhinopneumonitis Vaccine Product and Services
    Table 11. Nisseiken Co., Ltd. Equine Rhinopneumonitis Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. Nisseiken Co., Ltd. Recent Developments/Updates
    Table 13. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
    Table 14. Boehringer Ingelheim Major Business
    Table 15. Boehringer Ingelheim Equine Rhinopneumonitis Vaccine Product and Services
    Table 16. Boehringer Ingelheim Equine Rhinopneumonitis Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. Boehringer Ingelheim Recent Developments/Updates
    Table 18. Santa Cruz Animal Health Basic Information, Manufacturing Base and Competitors
    Table 19. Santa Cruz Animal Health Major Business
    Table 20. Santa Cruz Animal Health Equine Rhinopneumonitis Vaccine Product and Services
    Table 21. Santa Cruz Animal Health Equine Rhinopneumonitis Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 22. Santa Cruz Animal Health Recent Developments/Updates
    Table 23. Merck Basic Information, Manufacturing Base and Competitors
    Table 24. Merck Major Business
    Table 25. Merck Equine Rhinopneumonitis Vaccine Product and Services
    Table 26. Merck Equine Rhinopneumonitis Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 27. Merck Recent Developments/Updates
    Table 28. Global Equine Rhinopneumonitis Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Units)
    Table 29. Global Equine Rhinopneumonitis Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 30. Global Equine Rhinopneumonitis Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 31. Market Position of Manufacturers in Equine Rhinopneumonitis Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 32. Head Office and Equine Rhinopneumonitis Vaccine Production Site of Key Manufacturer
    Table 33. Equine Rhinopneumonitis Vaccine Market: Company Product Type Footprint
    Table 34. Equine Rhinopneumonitis Vaccine Market: Company Product Application Footprint
    Table 35. Equine Rhinopneumonitis Vaccine New Market Entrants and Barriers to Market Entry
    Table 36. Equine Rhinopneumonitis Vaccine Mergers, Acquisition, Agreements, and Collaborations
    Table 37. Global Equine Rhinopneumonitis Vaccine Sales Quantity by Region (2018-2023) & (K Units)
    Table 38. Global Equine Rhinopneumonitis Vaccine Sales Quantity by Region (2024-2029) & (K Units)
    Table 39. Global Equine Rhinopneumonitis Vaccine Consumption Value by Region (2018-2023) & (USD Million)
    Table 40. Global Equine Rhinopneumonitis Vaccine Consumption Value by Region (2024-2029) & (USD Million)
    Table 41. Global Equine Rhinopneumonitis Vaccine Average Price by Region (2018-2023) & (US$/Unit)
    Table 42. Global Equine Rhinopneumonitis Vaccine Average Price by Region (2024-2029) & (US$/Unit)
    Table 43. Global Equine Rhinopneumonitis Vaccine Sales Quantity by Type (2018-2023) & (K Units)
    Table 44. Global Equine Rhinopneumonitis Vaccine Sales Quantity by Type (2024-2029) & (K Units)
    Table 45. Global Equine Rhinopneumonitis Vaccine Consumption Value by Type (2018-2023) & (USD Million)
    Table 46. Global Equine Rhinopneumonitis Vaccine Consumption Value by Type (2024-2029) & (USD Million)
    Table 47. Global Equine Rhinopneumonitis Vaccine Average Price by Type (2018-2023) & (US$/Unit)
    Table 48. Global Equine Rhinopneumonitis Vaccine Average Price by Type (2024-2029) & (US$/Unit)
    Table 49. Global Equine Rhinopneumonitis Vaccine Sales Quantity by Application (2018-2023) & (K Units)
    Table 50. Global Equine Rhinopneumonitis Vaccine Sales Quantity by Application (2024-2029) & (K Units)
    Table 51. Global Equine Rhinopneumonitis Vaccine Consumption Value by Application (2018-2023) & (USD Million)
    Table 52. Global Equine Rhinopneumonitis Vaccine Consumption Value by Application (2024-2029) & (USD Million)
    Table 53. Global Equine Rhinopneumonitis Vaccine Average Price by Application (2018-2023) & (US$/Unit)
    Table 54. Global Equine Rhinopneumonitis Vaccine Average Price by Application (2024-2029) & (US$/Unit)
    Table 55. North America Equine Rhinopneumonitis Vaccine Sales Quantity by Type (2018-2023) & (K Units)
    Table 56. North America Equine Rhinopneumonitis Vaccine Sales Quantity by Type (2024-2029) & (K Units)
    Table 57. North America Equine Rhinopneumonitis Vaccine Sales Quantity by Application (2018-2023) & (K Units)
    Table 58. North America Equine Rhinopneumonitis Vaccine Sales Quantity by Application (2024-2029) & (K Units)
    Table 59. North America Equine Rhinopneumonitis Vaccine Sales Quantity by Country (2018-2023) & (K Units)
    Table 60. North America Equine Rhinopneumonitis Vaccine Sales Quantity by Country (2024-2029) & (K Units)
    Table 61. North America Equine Rhinopneumonitis Vaccine Consumption Value by Country (2018-2023) & (USD Million)
    Table 62. North America Equine Rhinopneumonitis Vaccine Consumption Value by Country (2024-2029) & (USD Million)
    Table 63. Europe Equine Rhinopneumonitis Vaccine Sales Quantity by Type (2018-2023) & (K Units)
    Table 64. Europe Equine Rhinopneumonitis Vaccine Sales Quantity by Type (2024-2029) & (K Units)
    Table 65. Europe Equine Rhinopneumonitis Vaccine Sales Quantity by Application (2018-2023) & (K Units)
    Table 66. Europe Equine Rhinopneumonitis Vaccine Sales Quantity by Application (2024-2029) & (K Units)
    Table 67. Europe Equine Rhinopneumonitis Vaccine Sales Quantity by Country (2018-2023) & (K Units)
    Table 68. Europe Equine Rhinopneumonitis Vaccine Sales Quantity by Country (2024-2029) & (K Units)
    Table 69. Europe Equine Rhinopneumonitis Vaccine Consumption Value by Country (2018-2023) & (USD Million)
    Table 70. Europe Equine Rhinopneumonitis Vaccine Consumption Value by Country (2024-2029) & (USD Million)
    Table 71. Asia-Pacific Equine Rhinopneumonitis Vaccine Sales Quantity by Type (2018-2023) & (K Units)
    Table 72. Asia-Pacific Equine Rhinopneumonitis Vaccine Sales Quantity by Type (2024-2029) & (K Units)
    Table 73. Asia-Pacific Equine Rhinopneumonitis Vaccine Sales Quantity by Application (2018-2023) & (K Units)
    Table 74. Asia-Pacific Equine Rhinopneumonitis Vaccine Sales Quantity by Application (2024-2029) & (K Units)
    Table 75. Asia-Pacific Equine Rhinopneumonitis Vaccine Sales Quantity by Region (2018-2023) & (K Units)
    Table 76. Asia-Pacific Equine Rhinopneumonitis Vaccine Sales Quantity by Region (2024-2029) & (K Units)
    Table 77. Asia-Pacific Equine Rhinopneumonitis Vaccine Consumption Value by Region (2018-2023) & (USD Million)
    Table 78. Asia-Pacific Equine Rhinopneumonitis Vaccine Consumption Value by Region (2024-2029) & (USD Million)
    Table 79. South America Equine Rhinopneumonitis Vaccine Sales Quantity by Type (2018-2023) & (K Units)
    Table 80. South America Equine Rhinopneumonitis Vaccine Sales Quantity by Type (2024-2029) & (K Units)
    Table 81. South America Equine Rhinopneumonitis Vaccine Sales Quantity by Application (2018-2023) & (K Units)
    Table 82. South America Equine Rhinopneumonitis Vaccine Sales Quantity by Application (2024-2029) & (K Units)
    Table 83. South America Equine Rhinopneumonitis Vaccine Sales Quantity by Country (2018-2023) & (K Units)
    Table 84. South America Equine Rhinopneumonitis Vaccine Sales Quantity by Country (2024-2029) & (K Units)
    Table 85. South America Equine Rhinopneumonitis Vaccine Consumption Value by Country (2018-2023) & (USD Million)
    Table 86. South America Equine Rhinopneumonitis Vaccine Consumption Value by Country (2024-2029) & (USD Million)
    Table 87. Middle East & Africa Equine Rhinopneumonitis Vaccine Sales Quantity by Type (2018-2023) & (K Units)
    Table 88. Middle East & Africa Equine Rhinopneumonitis Vaccine Sales Quantity by Type (2024-2029) & (K Units)
    Table 89. Middle East & Africa Equine Rhinopneumonitis Vaccine Sales Quantity by Application (2018-2023) & (K Units)
    Table 90. Middle East & Africa Equine Rhinopneumonitis Vaccine Sales Quantity by Application (2024-2029) & (K Units)
    Table 91. Middle East & Africa Equine Rhinopneumonitis Vaccine Sales Quantity by Region (2018-2023) & (K Units)
    Table 92. Middle East & Africa Equine Rhinopneumonitis Vaccine Sales Quantity by Region (2024-2029) & (K Units)
    Table 93. Middle East & Africa Equine Rhinopneumonitis Vaccine Consumption Value by Region (2018-2023) & (USD Million)
    Table 94. Middle East & Africa Equine Rhinopneumonitis Vaccine Consumption Value by Region (2024-2029) & (USD Million)
    Table 95. Equine Rhinopneumonitis Vaccine Raw Material
    Table 96. Key Manufacturers of Equine Rhinopneumonitis Vaccine Raw Materials
    Table 97. Equine Rhinopneumonitis Vaccine Typical Distributors
    Table 98. Equine Rhinopneumonitis Vaccine Typical Customers
List of Figures
    Figure 1. Equine Rhinopneumonitis Vaccine Picture
    Figure 2. Global Equine Rhinopneumonitis Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Equine Rhinopneumonitis Vaccine Consumption Value Market Share by Type in 2022
    Figure 4. Live Examples
    Figure 5. Inactivated Examples
    Figure 6. Global Equine Rhinopneumonitis Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 7. Global Equine Rhinopneumonitis Vaccine Consumption Value Market Share by Application in 2022
    Figure 8. Veterinary Pharmacy Examples
    Figure 9. Online Sale Examples
    Figure 10. Others Examples
    Figure 11. Global Equine Rhinopneumonitis Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 12. Global Equine Rhinopneumonitis Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 13. Global Equine Rhinopneumonitis Vaccine Sales Quantity (2018-2029) & (K Units)
    Figure 14. Global Equine Rhinopneumonitis Vaccine Average Price (2018-2029) & (US$/Unit)
    Figure 15. Global Equine Rhinopneumonitis Vaccine Sales Quantity Market Share by Manufacturer in 2022
    Figure 16. Global Equine Rhinopneumonitis Vaccine Consumption Value Market Share by Manufacturer in 2022
    Figure 17. Producer Shipments of Equine Rhinopneumonitis Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 18. Top 3 Equine Rhinopneumonitis Vaccine Manufacturer (Consumption Value) Market Share in 2022
    Figure 19. Top 6 Equine Rhinopneumonitis Vaccine Manufacturer (Consumption Value) Market Share in 2022
    Figure 20. Global Equine Rhinopneumonitis Vaccine Sales Quantity Market Share by Region (2018-2029)
    Figure 21. Global Equine Rhinopneumonitis Vaccine Consumption Value Market Share by Region (2018-2029)
    Figure 22. North America Equine Rhinopneumonitis Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 23. Europe Equine Rhinopneumonitis Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 24. Asia-Pacific Equine Rhinopneumonitis Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 25. South America Equine Rhinopneumonitis Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 26. Middle East & Africa Equine Rhinopneumonitis Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 27. Global Equine Rhinopneumonitis Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 28. Global Equine Rhinopneumonitis Vaccine Consumption Value Market Share by Type (2018-2029)
    Figure 29. Global Equine Rhinopneumonitis Vaccine Average Price by Type (2018-2029) & (US$/Unit)
    Figure 30. Global Equine Rhinopneumonitis Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 31. Global Equine Rhinopneumonitis Vaccine Consumption Value Market Share by Application (2018-2029)
    Figure 32. Global Equine Rhinopneumonitis Vaccine Average Price by Application (2018-2029) & (US$/Unit)
    Figure 33. North America Equine Rhinopneumonitis Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 34. North America Equine Rhinopneumonitis Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 35. North America Equine Rhinopneumonitis Vaccine Sales Quantity Market Share by Country (2018-2029)
    Figure 36. North America Equine Rhinopneumonitis Vaccine Consumption Value Market Share by Country (2018-2029)
    Figure 37. United States Equine Rhinopneumonitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 38. Canada Equine Rhinopneumonitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 39. Mexico Equine Rhinopneumonitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 40. Europe Equine Rhinopneumonitis Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 41. Europe Equine Rhinopneumonitis Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 42. Europe Equine Rhinopneumonitis Vaccine Sales Quantity Market Share by Country (2018-2029)
    Figure 43. Europe Equine Rhinopneumonitis Vaccine Consumption Value Market Share by Country (2018-2029)
    Figure 44. Germany Equine Rhinopneumonitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 45. France Equine Rhinopneumonitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 46. United Kingdom Equine Rhinopneumonitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 47. Russia Equine Rhinopneumonitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 48. Italy Equine Rhinopneumonitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 49. Asia-Pacific Equine Rhinopneumonitis Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 50. Asia-Pacific Equine Rhinopneumonitis Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 51. Asia-Pacific Equine Rhinopneumonitis Vaccine Sales Quantity Market Share by Region (2018-2029)
    Figure 52. Asia-Pacific Equine Rhinopneumonitis Vaccine Consumption Value Market Share by Region (2018-2029)
    Figure 53. China Equine Rhinopneumonitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 54. Japan Equine Rhinopneumonitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 55. Korea Equine Rhinopneumonitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 56. India Equine Rhinopneumonitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 57. Southeast Asia Equine Rhinopneumonitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 58. Australia Equine Rhinopneumonitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 59. South America Equine Rhinopneumonitis Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 60. South America Equine Rhinopneumonitis Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 61. South America Equine Rhinopneumonitis Vaccine Sales Quantity Market Share by Country (2018-2029)
    Figure 62. South America Equine Rhinopneumonitis Vaccine Consumption Value Market Share by Country (2018-2029)
    Figure 63. Brazil Equine Rhinopneumonitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 64. Argentina Equine Rhinopneumonitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 65. Middle East & Africa Equine Rhinopneumonitis Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 66. Middle East & Africa Equine Rhinopneumonitis Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 67. Middle East & Africa Equine Rhinopneumonitis Vaccine Sales Quantity Market Share by Region (2018-2029)
    Figure 68. Middle East & Africa Equine Rhinopneumonitis Vaccine Consumption Value Market Share by Region (2018-2029)
    Figure 69. Turkey Equine Rhinopneumonitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 70. Egypt Equine Rhinopneumonitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 71. Saudi Arabia Equine Rhinopneumonitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 72. South Africa Equine Rhinopneumonitis Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 73. Equine Rhinopneumonitis Vaccine Market Drivers
    Figure 74. Equine Rhinopneumonitis Vaccine Market Restraints
    Figure 75. Equine Rhinopneumonitis Vaccine Market Trends
    Figure 76. Porters Five Forces Analysis
    Figure 77. Manufacturing Cost Structure Analysis of Equine Rhinopneumonitis Vaccine in 2022
    Figure 78. Manufacturing Process Analysis of Equine Rhinopneumonitis Vaccine
    Figure 79. Equine Rhinopneumonitis Vaccine Industrial Chain
    Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 81. Direct Channel Pros & Cons
    Figure 82. Indirect Channel Pros & Cons
    Figure 83. Methodology
    Figure 84. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Zoetis
Nisseiken Co., Ltd.
Boehringer Ingelheim
Santa Cruz Animal Health
Merck

Related Reports

Global Equine Rhinopneumonitis Vaccine Supply, Demand and Key Producers, 2023-2029

Global Equine Rhinopneumonitis Vaccine Supply, Demand and Key Producers, 2023-2029

date 03 Feb 2023

date Pharma & Healthcare

The global Equine Rhinopneumonitis Vaccine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Equine Rhinopneumonitis Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Equine Rhinopneumonitis Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 10 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Equine Rhinopneumonitis Vaccine market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Global Equine Rhinopneumonitis Vaccine Supply, Demand and Key Producers, 2024-2030

Global Equine Rhinopneumonitis Vaccine Supply, Demand and Key Producers, 2024-2030

date 03 Mar 2024

date Pharma & Healthcare

The global Equine Rhinopneumonitis Vaccine market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

Equine Rhinopneumonitis Vaccine

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>